Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
10.14
+0.14 (1.40%)
At close: Jun 26, 2026, 4:00 PM EDT
10.07
-0.07 (-0.69%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Silence Therapeutics Employees
Silence Therapeutics had 88 employees as of December 31, 2025. The number of employees decreased by 28 or -24.14% compared to the previous year.
Employees
88
Change (1Y)
-28
Growth (1Y)
-24.14%
Revenue / Employee
$9,534
Profits / Employee
-$852,716
Market Cap
478.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cabaletta Bio | 158 |
| Sutro Biopharma | 133 |
| Neurogene | 131 |
| Ocugen | 116 |
| C4 Therapeutics | 104 |
| Assembly Biosciences | 73 |
| Prothena Corporation | 67 |
SLN News
- 4 days ago - Cantor starts ‘materially undervalued’ Silence Therapeutics at Overweight - TheFly
- 4 days ago - Silence Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 5 days ago - Silence Therapeutics Slides: Corporate presentation - Filings
- 17 days ago - Silence Therapeutics highlights follow-up data on divesiran at EHA 2026 - TheFly
- 17 days ago - Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera - Business Wire
- 24 days ago - Silence Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Silence Therapeutics to Participate in Jefferies Global Healthcare Conference - Business Wire
- 5 weeks ago - Silence Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts